A doctor looking to help a patient prescribes a medication for a condition it was not originally marketed to treat. How legal, and how risky the off-label use of prescription drugs?On Thursday's Up To Date Steve Kraske talks with a pharmacist about just how common this practice is among physicians and why drug companies don’t market their products for multiple uses.
Rick Couldry is Director of Pharmacy at the University of Kansas Hospital.
In the past, the standard treatments for hepatitis C have been nearly as bad as the disease, making some patients feel like they have a severe flu. And, even with treatment, hepatitis C often doesn’t get better. But things could be changing for the over three million people infected in the United States. A new class of improved hepatitis C drugs is emerging, and they're being tested in Kansas City.
“When you get a call that says you’ve got hepatitis, it’s a wakeup call,” says 57-year old Bob Barber.